Along with key academic and pharmaceutical partners, Siemens is leading the charge to improve and expand the effectiveness of radiation to treat rare neuroendocrine tumors with a revolutionary new type of targeted radiotherapy used in conjunction with SPECT imaging technology.

By Tim Friend

Moving targets have always been a challenge for radiotherapy. Methods like increasing the planning target volume or gating have the disadvantage of reducing the precision of the treatment or prolonging the treatment sessions. For particle therapy with scanned ion beams, an international team at GSI is evaluating a new method with promising results: tumor tracking.

By C. Bert, PhD; A. Schmidt; N. Saito, PhD; N. Chaudhri; D. Schardt, PhD; G. Kraft, PhD; E. Rietzel, PhD